Peptide YY (3-36) (human) Acetate

Peptide YY (3-36) (human) Acetate is a synthetic fragment of the naturally occurring human peptide YY, a gut-derived hormone belonging to the pancreatic polypeptide family. As a truncated form, it is distinguished by its sequence beginning at the third amino acid, which imparts unique biological properties compared to the full-length peptide. This compound is widely recognized for its ability to interact selectively with specific Y receptors, particularly Y2, making it a valuable tool in the exploration of appetite regulation and energy homeostasis. Its stability as an acetate salt further enhances its utility in laboratory settings, ensuring consistent performance in a range of experimental protocols. Researchers benefit from its high sequence fidelity and predictable activity profile, which facilitate reproducible results in both in vitro and in vivo studies. By leveraging the biological actions of Peptide YY (3-36), scientists can gain deeper insights into the complex interplay between the gut and the central nervous system, especially in the context of metabolic and neuroendocrine research.

Appetite Regulation Studies: Peptide YY (3-36) (human) Acetate is extensively employed in investigations aimed at elucidating the molecular mechanisms underlying appetite suppression and satiety signaling. Through its high affinity for the Y2 receptor, this peptide fragment effectively inhibits food intake in various experimental models, providing a robust platform for dissecting the pathways that govern feeding behavior. Its use enables researchers to delineate the downstream signaling cascades activated upon receptor binding, thereby identifying potential molecular targets for modulating energy balance. By administering this compound in controlled settings, scientists can observe changes in neuronal activity, hormone secretion, and behavioral responses, all of which contribute to a comprehensive understanding of appetite regulation.

Obesity and Metabolic Disorder Research: In the context of obesity and metabolic syndrome, Peptide YY (3-36) is leveraged to study the physiological and biochemical changes associated with altered energy homeostasis. Its ability to modulate appetite and influence metabolic rate makes it an invaluable asset for modeling disease states and testing the efficacy of novel therapeutic interventions. Investigators utilize this peptide to simulate the effects of endogenous satiety hormones, thereby assessing the impact of Y2 receptor activation on weight gain, glucose metabolism, and lipid profiles. Such research is instrumental in uncovering the mechanisms that drive metabolic dysregulation and in identifying strategies to restore balance in affected individuals.

Gut-Brain Axis Exploration: The acetate form of Peptide YY (3-36) is a key reagent in studies examining the bidirectional communication between the gastrointestinal tract and the central nervous system. By tracking its effects on neuronal circuits and neurotransmitter release, researchers can map the influence of gut-derived signals on mood, cognition, and stress responses. This work sheds light on the broader implications of peptide signaling in neurogastroenterology, including the development of functional gastrointestinal disorders and the interplay between diet, microbiota, and brain function. The peptide's selective receptor activity allows for precise manipulation of signaling pathways, fostering a deeper understanding of gut-brain interactions.

Nutrient Sensing and Digestive Physiology: Scientists also utilize this peptide fragment to probe the role of nutrient sensing in digestive processes. By administering it in conjunction with various dietary components, researchers can monitor changes in gastrointestinal motility, hormone release, and nutrient absorption. These studies reveal how the gut adapts to different nutritional states and how peptide signals contribute to the regulation of digestive efficiency. Insights gained from such experiments inform the design of targeted nutritional interventions and enhance our knowledge of the physiological mechanisms that maintain energy balance.

Endocrine Signaling Pathway Analysis: The application of Peptide YY (3-36) (human) Acetate extends to the investigation of endocrine signaling networks, particularly those involving peptide hormones and their receptors. By integrating this compound into cell-based assays and animal models, researchers can assess the specificity and potency of receptor-ligand interactions, map intracellular signaling events, and evaluate the cross-talk between different hormonal systems. These studies are critical for advancing our understanding of hormone action in health and disease and for identifying novel points of intervention in metabolic and neuroendocrine disorders. The versatility and well-characterized activity of this peptide make it a preferred choice for unraveling the complexities of endocrine regulation in diverse biological contexts.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII